je.st
news
Ironwood starts IBS trial in China, but stock falls on analyst forecast
2013-09-12 13:48:54| Biotech - Topix.net
Ironwood Pharmaceuticals Inc. has announced a late-stage trial in China seeking to get its irritable bowel syndrome drug approved there, but lost 4 percent of stock value after an analyst firm lowered his price target.
Tags: china
stock
trial
falls
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||